Jared W Magnani

Contributions to Public Health

• I am a non-invasive cardiologist with commitment to public health. My practice integrates individualized approaches to address social and structural barriers; I initiated a cardiology clinic at the Mathilda Theiss Family Medicne clinic—a long-standing clinic that serves the health of Hill District residents—to embed cardiology where people receive primary care and eliminate geographic obstacles to care. I appreciate public health as occurring in the exam room, the community, and our society.
• My goals as a clinician-investigator are two-fold: (1) identify social risk factors and social determinants that contribute towards and exacerbate cardiovascular health outcomes; and (2) develop novel, scalable interventions to address social risk factors and evaluate their effectiveness, implementation, and scalability in robust clinical trials. My NIH-funded trials have engaged individuals with limited access to clinical research, such as rural individuals and those with limited health literacy. Citations:
  • Magnani JW, Plevniak K, Ferry D, Martin D, Brooks MM, Kimani E, Ólafsson S, Rollman BL, Paasche-Orlow MK, El Khoudary SR, Bickmore T. The mobile health intervention for rural patients with atrial fibrillation: a randomized controlled trial. Int J Cardiol. 2025;438:133575.
  • Magnani JW, Lalama CM, Abebe KZ, Ferry D, Rollman BL, Lancet MQ, Kimani E, Ólafsson S, Bickmore T, Paasche-Orlow MK. A mobile relational agent to enhance atrial fibrillation self-care: Primary and secondary outcomes of a randomized controlled trial. Am Heart J. 2025;290:115-128.
• I have focused on social and structural factors in relation to cardiovascular health. These investigations have employed novel approaches to identify modifiable risk factors for cardiovascular adversity and been conducted in collaboration with longitudinal cohorts and administrative data. Citations:
  • Magnani JW, Ning H, Wilkins JT, Lloyd-Jones DM, Allen NB. Educational attainment and lifetime risk of cardiovascular disease. JAMA Cardiol. 2024;9(1):45-54.
  • Essien UR, Singh B, Swabe G, Johnson AE, Eberly LA, Wadhera RK, Breathett K, Vaduganathan M, Magnani JW. Association of prescription co-payment with adherence to glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter-2 inhibitor therapies in patients with heart failure and diabetes. JAMA Netw Open. 2023;6(6):e2316290.
• I have focused on individual and organizational health literacy because of its importance to health equity, patient care, and preventable health care utilization. I have led initiatives in the American Heart Association to address health literacy and have examined its effect on individuals with cardiovascular disease.
  • Magnani JW, Mujahid MS, Aronow HD, Cené CW, Dickson VV, Havranek E, Morgenstern LB, Paasche-Orlow MK, Pollak A, Willey JZ. Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: A Scientific Statement from the American Heart Association. Circulation. 2018;138:e48-e74.
  • Benjamin EJ, Thomas KL, Go AS, Desvigne-Nickens P, Albert CM, Alonso A, Chamberlain AM, Essien UR, Hernandez I, Hills MT, Kershaw KN, Levy PD, Magnani JW, Matlock DD, O'Brien EC, Rodriguez CJ, Russo AM, Soliman EZ, Cooper LS, Al-Khatib SM. Transforming Atrial Fibrillation research to integrate social determinants of health: a National Heart, Lung, and Blood Institute Workshop Report. JAMA Cardiol. 2023;8:182-191.